---
document_datetime: 2024-10-02 10:22:13
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/celsentri-epar-all-authorised-presentations_en.pdf
document_name: celsentri-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.7978135
conversion_datetime: 2025-12-19 06:20:56.294008
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of administration   | Immediate Packaging   | Content (concentration)   | Package size                             |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|---------------------------|------------------------------------------|
| EU/1/07/418/001  | Celsentri         | 150 mg     | Film-coated tablet    | Oral use                  | Bottle (HDPE/alu)     |                           | 60 tablets                               |
| EU/1/07/418/002  | Celsentri         | 150 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/alu)     |                           | 30 tablets                               |
| EU/1/07/418/003  | Celsentri         | 150 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/alu)     |                           | 60 tablets                               |
| EU/1/07/418/004  | Celsentri         | 150 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/alu)     |                           | 90 tablets                               |
| EU/1/07/418/005  | Celsentri         | 150 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/alu)     |                           | 180 (2x90) tablets(multipack)            |
| EU/1/07/418/006  | Celsentri         | 300 mg     | Film-coated tablet    | Oral use                  | Bottle (HDPE/alu)     |                           | 60 tablets                               |
| EU/1/07/418/007  | Celsentri         | 300 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/alu)     |                           | 30 tablets                               |
| EU/1/07/418/008  | Celsentri         | 300 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/alu)     |                           | 60 tablets                               |
| EU/1/07/418/009  | Celsentri         | 300 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/alu)     |                           | 90 tablets                               |
| EU/1/07/418/010  | Celsentri         | 300 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/alu)     |                           | 180 (2x90) tablets (multipack)           |
| EU/1/07/418/011  | Celsentri         | 25 mg      | Film-coated tablet    | Oral use                  | bottle (HDPE/alu)     |                           | 120 tablets                              |
| EU/1/07/418/012  | Celsentri         | 75 mg      | Film-coated tablet    | Oral use                  | bottle (HDPE/alu)     |                           | 120 tablets                              |
| EU/1/07/418/013  | Celsentri         | 20 mg/ml   | Oral solution         | Oral use                  | bottle (HDPE)         | 230 ml                    | 1 bottle + 1 adapter + 1 oral applicator |